新成立的31亿美元基金会对生物科学、人工智能和环境进行了长期的重大投资

IF 101.8 1区医学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Nature Reviews. Drug Discovery Pub Date : 2025-09-12 DOI:10.1038/d41573-025-00154-3

Asher Mullard

引用次数: 0

摘要

新成立的科技基金总裁兼首席执行官Lynda Stuart讨论了该慈善组织在生物科学和人工智能方面的计划。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

New US$3.1 billion foundation takes big, long-term bets on bioscience, AI and the environment

查看原文本刊更多论文

New US$3.1 billion foundation takes big, long-term bets on bioscience, AI and the environment

Lynda Stuart, president and CEO of the newly launched Fund for Science and Technology, discusses the philanthropic organization’s plans for bioscience and AI. Lynda Stuart, president and CEO of the newly launched Fund for Science and Technology, discusses the philanthropic organization’s plans for bioscience and AI.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Reviews. Drug Discovery 医学-生物工程与应用微生物

CiteScore

137.40

自引率

0.30%

发文量

227

期刊介绍： Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. Each issue includes: Highest-quality reviews and perspectives covering a broad scope. News stories investigating the hottest topics in drug discovery. Timely summaries of key primary research papers. Concise updates on the latest advances in areas such as new drug approvals, patent law, and emerging industry trends and strategies.